Bayesian Capital Management’s Microvision MVIS Stock Holding History

Bayesian Capital Management’s Portfolio MVIS Stock Details MVIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-55,100	Closed	-$62.8K	–	879
2024 Q3	$62.8K	Buy	+55,100	New	+$57.2K	0.01%	616
2023 Q4	–	Sell	-19,900	Closed	-$43.6K	–	937
2023 Q3	$43.6K	Sell	19,900 -23,500	-54%	-$71.7K	0.01%	639
2023 Q2	$199K	Buy	43,400 +32,800	+309%	+$115K	0.02%	641
2023 Q1	$28.3K	Buy	+10,600	New	+$26.8K	﹤0.01%	725
2022 Q2	–	Sell	-69,400	Closed	-$324K	–	975
2022 Q1	$324K	Buy	+69,400	New	+$274K	0.05%	498
2021 Q2	–	Sell	-16,844	Closed	-$312K	–	562
2021 Q1	$312K	Buy	+16,844	New	+$212K	0.07%	343
2019 Q1	–	Sell	-12,762	Closed	-$8K	–	691
2018 Q4	$8K	Buy	+12,762	New	+$12K	﹤0.01%	590

Other funds holding MVIS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bayesian Capital Management's MVIS Position: Q4 2024 in Review

Bayesian Capital Management sold out of Microvision (MVIS) in Q4 2024, closing a stake of 55,100 shares — an estimated $62.8K sold.

Bayesian Capital Management first reported a position in MVIS in Q4 2018 and held it in 7 quarters. The position peaked at $324K in Q1 2022. 143 funds tracked by Wall St. Rank hold MVIS as of Q4 2024.

Bayesian Capital Management reported no remaining Microvision position as of Q4 2024 after selling out during the quarter.
Bayesian Capital Management sold 55,100 Microvision shares in Q4 2024, an estimated $62.8K.
Bayesian Capital Management first reported a position in Microvision in Q4 2018 and held it in 7 quarters.
Bayesian Capital Management's Microvision position peaked at $324K in Q1 2022.
143 funds tracked by Wall St. Rank held Microvision as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.